Nuveen Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-280,066
| Closed | -$5.28M | – | 3249 |
|
|
2019
Q3 | $5.28M | Buy |
280,066
+5,635
| +2% | +$106K | ﹤0.01% | 1923 |
|
|
2019
Q2 | $3.23M | Buy |
+274,431
| New | +$3.23M | ﹤0.01% | 2214 |
|
|
2017
Q2 | – | Sell |
-66,224
| Closed | -$1.38M | – | 1363 |
|
|
2017
Q1 | $1.38M | Buy |
66,224
+17,760
| +37% | +$369K | 0.01% | 838 |
|
|
2016
Q4 | $1.01M | Buy |
48,464
+8,378
| +21% | +$174K | 0.01% | 1137 |
|
|
2016
Q3 | $1.31M | Buy |
40,086
+7,198
| +22% | +$236K | 0.01% | 973 |
|
|
2016
Q2 | $821K | Buy |
+32,888
| New | +$821K | 0.01% | 1065 |
|